Treatment Management Company

TMC Pharma Services, officially registered as Treatment Management Company Limited, is a global pharmaceutical and biotechnology consultancy and contract research organization (CRO). The company provides a full range of drug development services, including clinical trial management, regulatory affairs, medical writing, and pharmacovigilance. TMC is particularly recognized for its deep expertise in orphan drugs and rare diseases, as well as oncology and advanced therapy medicinal products (ATMPs). Headquartered in the UK, the firm supports small to mid-sized life science companies in navigating the complexities of global drug development and market access. In 2022, TMC was acquired by The Planet Group, a portfolio company of Odyssey Investment Partners, to enhance its global life sciences service offerings.